Antioxidants in the treatment of severe pre-eclampsis an explanatory randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 6, 1997, Pages 689-696

  Gülmezoǧlu, A Metin ^a   Hofmeyr, G Justus ^a   Oosthuisen, Mathys M J ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; IRON; LIPID PEROXIDE; MAGNESIUM SULFATE; MALONALDEHYDE; METHYLDOPA; NIFEDIPINE; PLACEBO; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ACNE; ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FETUS OUTCOME; HUMAN; IRON THERAPY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MUSCLE WEAKNESS; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SOUTH AFRICA; TABLET; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ALLOPURINOL; ANTIOXIDANTS; ASCORBIC ACID; DOUBLE-BLIND METHOD; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIPID PEROXIDES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; URIC ACID; VITAMIN E;

EID: 0030913177     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11979.x     Document Type: Article

References (32)

1. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451.
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–1204.
3. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preelampsia. Am J Obstet Gynecol 1989; 161: 1025–1034.
4. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Preg 1994; 13: 1–32.
5. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: Where are we now J Lab Clin Med 1992; 119: 598–620.
6. Redman CWG, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 1: 1370–1373.
7. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R. Maternal Fetal Medicine: Principles and Practice. Philadelphia : Wb Saunders, 1989: 777–823.
8. Fay RA. Uric acid in pregnancy and preeclampsia: An alternative hypothesis. Aust N Z J Obstet Gynaecol 1990; 30: 141–142.
9. Simmonds HA, Stutchbury JH, Webster DR et al. Pregnancy in xan-thinuria: Demonstration of fetal uric acid production. J Inherit Metab Dis 1984; 7: 77–79.
10. Fox IH, Palella TD, Kelley WN. Hyperuricemia: A marker for cell energy crisis. N Engl J Med 1987; 317: 111–112.
11. Christensen EF, Jacobsen J, Anker-Moller E, Schultz P, Spangsberg N. Increased urinary loss of uric acid in adults with acute respiratory failure requiring mechanical ventilation. Chest 1992; 102: 556–559.
12. Vannucci RC. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1990; 85: 961–968.
13. Giacoia GP. Asphyxial brain damage in the newborn: New insights into pathophysiology and possible pharmacologic interventions. South Med J 1993; 66: 676–682.
14. Torbergsen T, Oian P, Mathiesen E, Borud O. Pre-eclampsia—a mito-chondrial disease Acta Obstet Gynecol Scand 1989; 68: 145–148.
15. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia II. Mitochondrial changes. Am J Obstet Gynecol 1990; 163: 943–953.
16. Carroli G, Duley L, Belizan JM, Villar J. Calcium supplementation during pregnancy: A systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994; 101: 753–758.
17. Stein HJ, Oosthuizen MMJ, Hinder RA, Lamprechts H. Effect of vera-pamil on ischaemia/reperfusion injury. Am J Surg 1993; 165: 96–100.
18. Gülmezoglu AM, Hofmeyr GJ, Oosthuizen MMJ. Lipid peroxidation in eclampsia. J Obstet Gynaecol 1997. In press.
19. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze VWTJ. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 1990; 76: 1070–1075.
20. Sibai BM. Management and counselling of patients with preeclampsia remote from term. Clin Obstet Gynecol 1992; 35: 426–437.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochem 1979; 95: 351–358.
22. Chou PP, Jaynes PK, Bailey Jl. Determination of vitamin E in microsamples of serum by liquid chromatography with electrochemical detection. Clin Chem 1985; 31: 880–882.
23. Gülmezoglu AM, Oosthuizen MMJ, Hofmeyr GJ. Placental malondi-aldehyde and glutathione levels in a controlled trial of antioxidant treatment in severe pre-eclampsia. Hypertens Preg 1996; 15: 287–295.
24. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994; 84: 626–630.
25. Olah KS, Redman CWG, Gee H. Management of severe, early pre-eclampsia: Is conservative management justified Eur J Obstet Gynecol Reprod Biol 1993; 51: 175–180.
26. Moodley J, Koranteng SA, Rout C. Expectant management of early onset severe pre-eclampsia in Durban. S Afr Med J 1993; 83: 584–587.
27. Pattinson RC, Odendaal HJ, Du Toil R. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J 1988; 73: 516–518.
28. Duthie GG, Arthur JR, James WPT. Effect of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 1991; 53: 1061S–1063S.
29. Brown KM, Morrice PC, Duthie GG. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr 1994; 60: 383–387.
30. Wang Y, Walsh SW, Guo J, Zhang J. The imbalance between throm-boxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991; 165: 1695–1700.
31. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: Does this indicate the mechanism of leucocyte activation BrJ Obstet Gynaecol, 1994; 101: 485–487.
32. Meydani M. Vitamin E. Lancet 1995; 345: 170–175.